Leningradskay Oblast, Russia

Vladimir Ivanovich Pereguda

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vladimir Ivanovich Pereguda. Retrieved from https://idiyas.com/inventor/vladimir-ivanovich-pereguda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,513 
Other
 patents

Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Vladimir Ivanovich Pereguda: Innovator in HSP70 Fusion Protein Therapies

Introduction

Vladimir Ivanovich Pereguda is a notable inventor based in Leningradskay Oblast, Russia. He has made significant contributions to the field of biotechnology, particularly in the development of novel therapies utilizing HSP70 fusion proteins. His work aims to address various disorders regulated by HSP70, showcasing his commitment to advancing medical science.

Latest Patents

Vladimir holds a patent for "HSP70 fusion protein conjugates and uses thereof." This invention relates to innovative therapies that leverage HSP70 fusion proteins for treating conditions influenced by HSP70. His patent represents a significant step forward in therapeutic options for patients suffering from related disorders. He has 1 patent to his name.

Career Highlights

Throughout his career, Vladimir has focused on the intersection of protein science and therapeutic applications. His research has contributed to a deeper understanding of HSP70 and its potential in medical treatments. His dedication to innovation in this field has positioned him as a key figure in biotechnology.

Collaborations

Vladimir has worked alongside esteemed colleagues, including Sergei B Onikienko and Alex Nivorozhkin. Their collaborative efforts have furthered research and development in the area of HSP70 fusion proteins, enhancing the potential for impactful medical therapies.

Conclusion

Vladimir Ivanovich Pereguda's work in HSP70 fusion proteins exemplifies the spirit of innovation in biotechnology. His contributions are paving the way for new therapeutic approaches that could significantly benefit patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…